TABLE 7. Reported cases of notifiable diseases and rates per 100,000 population, by ethnicity*, excluding U.S. territories - - United States, 2016 column labels in same order that data fields appears in each record below: Disease Hispanic, No. Hispanic, Rate Non-Hispanic, No. Non-Hispanic, Rate Ethnicity not stated, No. Total, No. tab delimited data: Anthrax — — — — — — Arboviral diseases, Chikungunya virus disease 60 0.10 132 0.05 55 247 Arboviral diseases, Eastern equine encephalitis virus disease, Neuroinvasive S S S S S 7 Arboviral diseases, Eastern equine encephalitis virus disease, Non-neuroinvasive — — — — — — Arboviral diseases, Jamestown Canyon virus disease, Neuroinvasive S S S S S 7 Arboviral diseases, Jamestown Canyon virus disease, Non-neuroinvasive S S S S S 8 Arboviral diseases, La Crosse virus disease, Neuroinvasive 1 0.00 20 0.01 10 31 Arboviral diseases, La Crosse virus disease, Non-neuroinvasive S S S S S 4 Arboviral diseases, Powassan virus disease, Neuroinvasive S S S S S 21 Arboviral diseases, Powassan virus disease, Non-neuroinvasive S S S S S 1 Arboviral diseases, St. Louis encephalitis virus disease, Neuroinvasive S S S S S 7 Arboviral diseases, St. Louis encephalitis virus disease, Non-neuroinvasive S S S S S 1 Arboviral diseases, West Nile virus disease, Neuroinvasive 160 0.28 841 0.32 307 1,308 Arboviral diseases, West Nile virus disease, Non-neuroinvasive 33 0.06 581 0.22 227 841 Arboviral diseases, Western equine encephalitis virus disease, Neuroinvasive — — — — — — Arboviral diseases, Western equine encephalitis virus disease, Non-neuroinvasive — — — — — — Babesiosis, Total 72 0.17 1,011 0.54 827 1,910 Babesiosis, Confirmed 63 0.15 818 0.44 704 1,585 Babesiosis, Probable 9 0.02 193 0.10 123 325 Botulism, Total 39 0.07 119 0.04 43 201 Botulism, Foodborne 4 0.01 18 0.01 9 31 Botulism, Infant † 28 2.73 87 2.95 29 144 Botulism, Other (wound & unspecified) 7 0.01 14 0.01 5 26 Brucellosis 69 0.12 43 0.02 15 127 Campylobacteriosis 7,367 12.82 33,388 12.57 19,365 60,120 Chancroid S S S S S 7 Chlamydia trachomatis infection 212,027 368.93 767,700 288.98 618,627 1,598,354 Cholera S S S S S 15 Coccidioidomycosis § 1,964 8.04 3,301 3.09 6,564 11,829 Cryptosporidiosis, Total 1,137 1.98 8,867 3.34 3,449 13,453 Cryptosporidiosis, Confirmed 827 1.44 5,615 2.11 2,195 8,637 Cryptosporidiosis, Probable 310 0.54 3,252 1.22 1,254 4,816 Cyclosporiasis 106 0.19 320 0.13 111 537 Dengue virus infections, Dengue ¶ 200 0.35 498 0.19 205 903 Dengue virus infections, Dengue-like illness ¶ 8 0.01 21 0.01 11 40 Dengue virus infections, Severe dengue ¶ S S S S S 10 Diphtheria — — — — — — Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection 52 0.09 2,557 1.00 1,542 4,151 Ehrlichiosis and Anaplasmosis, Ehrlichia chaffeensis infection 28 0.05 918 0.36 431 1,377 Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection S S S S S 22 Ehrlichiosis and Anaplasmosis, Undetermined ehrlichiosis/anaplasmosis 2 0.00 126 0.05 72 200 Giardiasis 1,063 2.50 8,829 4.18 6,418 16,310 Gonorrhea 54,300 94.48 277,814 104.58 136,400 468,514 Haemophilus influenzae, invasive disease, All ages, all serotypes 289 0.50 3,118 1.17 1,488 4,895 Haemophilus influenzae, invasive disease, Age <5 years, Serotype b ** 1 0.02 19 0.13 10 30 Haemophilus influenzae, invasive disease, Age <5 years, Non-b serotype ** 12 0.23 107 0.72 40 159 Haemophilus influenzae, invasive disease, Age <5 years, Nontypeable ** 28 0.54 109 0.74 59 196 Haemophilus influenzae, invasive disease, Age <5 years, Unknown serotype ** 35 0.68 104 0.70 48 187 Hansen's disease 10 0.02 48 0.02 20 78 Hantavirus infection, non-hantavirus pulmonary syndrome S S S S S 6 Hantavirus pulmonary syndrome 4 0.01 23 0.01 4 31 Hemolytic uremic syndrome post-diarrheal 36 0.06 228 0.09 43 307 Hepatitis, A, acute †† 293 0.51 1,232 0.46 482 2,007 Hepatitis, B, acute †† 194 0.34 2,272 0.86 752 3,218 Hepatitis, B, perinatal infection ††,§§ — — 19 0.32 13 32 Hepatitis, C, acute †† 191 0.35 1,941 0.78 810 2,942 Human immunodeficiency virus diagnoses 8,076 14.05 26,699 10.05 — 34,775 Influenza-associated pediatric mortality ¶¶ 20 0.11 49 0.09 13 82 Invasive pneumococcal disease, All ages 1,119 3.04 10,584 5.19 5,923 17,626 Invasive pneumococcal disease, All ages, Confirmed 1,119 3.04 10,570 5.18 5,914 17,603 Invasive pneumococcal disease, All ages, Probable S S S S S 23 Invasive pneumococcal disease, Age <5 years ** 182 0.46 666 0.30 294 1,142 Invasive pneumococcal disease, Age <5 years, Confirmed ** 182 5.08 663 5.36 292 1,137 Invasive pneumococcal disease, Age <5 years, Probable ** S S S S S 5 Legionellosis 397 0.69 4,506 1.70 1,238 6,141 Leptospirosis 7 0.02 52 0.03 19 78 Listeriosis 87 0.15 564 0.21 135 786 Lyme disease, Total 546 0.95 13,833 5.23 22,050 36,429 Lyme disease, Confirmed 365 0.64 9,666 3.66 16,172 26,203 Lyme disease, Probable 181 0.32 4,167 1.58 5,878 10,226 Malaria 59 0.10 1,492 0.56 404 1,955 Measles, Total 6 0.01 44 0.02 35 85 Measles, Indigenous 6 0.01 29 0.01 33 68 Measles, Imported S S S S S 17 Meningococcal disease, All serogroups 55 0.10 262 0.10 58 375 Meningococcal disease, Serogroups ACWY 17 0.03 91 0.03 18 126 Meningococcal disease, Serogroup B 6 0.01 67 0.03 13 86 Meningococcal disease, Other serogroups S S S S S 21 Meningococcal disease, Unknown serogroup 30 0.05 88 0.03 24 142 Mumps 596 1.04 4,685 1.76 1,088 6,369 Novel Influenza A virus infections S S S S S 23 Pertussis 2,396 4.17 10,358 3.90 5,218 17,972 Plague S S S S S 4 Poliomyelitis, paralytic — — — — — — Poliovirus infection, nonparalytic — — — — — — Psittacosis S S S S S 12 Q fever, Total 22 0.04 88 0.03 54 164 Q fever, Acute 20 0.03 73 0.03 39 132 Q fever, Chronic 2 0.00 15 0.01 15 32 Rabies, Human — — — — — — Rubella S S S S S 1 Rubella, congenital syndrome † S S S S S 2 Salmonellosis 7,406 12.89 33,064 12.45 13,380 53,850 Severe acute respiratory syndrome-associated coronavirus disease — — — — — — Shiga toxin-producing Escherichia coli *** 1,274 2.22 4,984 1.88 1,911 8,169 Shigellosis 4,919 8.56 11,539 4.34 4,639 21,097 Smallpox — — — — — — Spotted fever rickettsiosis, Total 108 0.19 2,887 1.09 1,274 4,269 Spotted fever rickettsiosis, Confirmed 4 0.01 93 0.04 57 154 Spotted fever rickettsiosis, Probable 104 0.18 2,794 1.06 1,217 4,115 Streptococcal toxic shock syndrome 23 0.10 201 0.11 59 283 Syphilis, Total, all stages ††† 22,694 39.49 58,751 22.12 6,597 88,042 Syphilis, Congenital † 187 18.24 407 13.82 34 628 Syphilis, Primary and secondary 6,193 10.78 19,791 7.45 1,830 27,814 Tetanus 4 0.01 20 0.01 10 34 Toxic shock syndrome (other than Streptococcal) 5 0.01 25 0.01 10 40 Trichinellosis 1 0.00 20 0.01 5 26 Tuberculosis 2,601 4.53 6,656 2.51 15 9,272 Tularemia 10 0.02 174 0.07 46 230 Typhoid fever 40 0.07 281 0.11 55 376 Vancomycin-intermediate Staphylococcus aureus 5 0.01 78 0.04 25 108 Vancomycin-resistant Staphylococcus aureus — — — — — — Varicella morbidity 1,559 3.05 5,034 2.41 2,360 8,953 Varicella mortality U U U U U U Vibriosis, Total 127 0.22 843 0.32 303 1,273 Vibriosis, Confirmed 125 0.22 818 0.31 298 1,241 Vibriosis, Probable 2 0.00 25 0.01 5 32 Viral hemorrhagic fevers, Crimean-Congo hemorrhagic fever virus — — — — — — Viral hemorrhagic fevers, Ebola virus — — — — — — Viral hemorrhagic fevers, Guanarito virus — — — — — — Viral hemorrhagic fevers, Junin virus — — — — — — Viral hemorrhagic fevers, Lassa virus — — — — — — Viral hemorrhagic fevers, Lujo virus — — — — — — Viral hemorrhagic fevers, Machupo virus — — — — — — Viral hemorrhagic fevers, Marburg virus — — — — — — Viral hemorrhagic fevers, Sabia virus — — — — — — Yellow fever S S S S S 1 Zika virus, Zika virus disease, congenital †,§§§ 18 1.76 5 0.17 7 30 Zika virus, Zika virus disease, non-congenital 2,079 3.62 1,680 0.63 1,373 5,132 Zika virus, Zika virus infection, congenital †,§§§ 16 1.56 3 0.10 26 45 Zika virus, Zika virus infection, non-congenital 463 0.81 262 0.10 186 911 —: No reported cases - The reporting jurisdiction did not submit any cases to CDC. U: Unavailable - The data are unavailable. S: Suppressed * Conditions with <25 cases reported in the year were not broken down by ethnicity. † The rate is calculated using population less than 1 year of age. § Reportable in <25 states. ¶ Total number of reported laboratory-positive dengue cases, including all confirmed cases [by anti-dengue virus (DENV) molecular diagnostic methods or seroconversion of anti-DENV IgM] and all probable cases (by a single, positive anti-DENV IgM). ** The rate is calculated using population less than 5 years of age. †† Chronic hepatitis B and C data are not included in NNDSS tables but reported case counts are included in the annual Summary of Viral Hepatitis, published online by CDC's Division of Viral Hepatitis, available at https://www.cdc.gov/hepatitis/statistics/2015surveillance/index.htm. §§ The rate is calculated using population less than 2 years of age. ¶¶ The rate is calculated using population less than 18 years of age. *** Includes Escherichia coli O157:H7; shiga toxin-positive, serogroup non-O157; and shiga toxin positive, not serogrouped. ††† Includes syphilis of all stages, including cases where stage of syphilis is not stated. §§§ Data reported to ArboNET using the national surveillance case definition for congenital Zika virus disease or infection (CSTE Position Statement 16-ID-01). Additional data reported to the US Zika Pregnancy Registry for outcomes of pregnancies with laboratory evidence of possible Zika virus infection are available at https://www.cdc.gov/zika/reporting/pregnancy-outcomes.html. Cases reported to the US Zika Pregnancy Registry might not meet the national surveillance case definition for congenital Zika virus disease or infection. Notes: These are annual cases of selected infectious national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published. Cases are reported by state health departments to CDC weekly. Because source datasets may be updated as additional information is received, statistics in publications based on that source data may differ from what is presented in these tables. The list of nationally notifiable infectious diseases and conditions for 2016 and their national surveillance case definitions are available by navigating to the https://ndc.services.cdc.gov/, Surveillance Case Definitions | CDC web page, selecting "2016" for the notifiable condition list year, checking "infectious" conditions, and clicking "Get Notifiable List by Year". This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved in 2015 by CSTE for national surveillance, that were implemented in January 2016, including updated surveillance case definitions for acute hepatitis C and chronic hepatitis C virus infections. 2016 data are reported through June 30, 2017. Publication criteria for the finalized 2016 data are available at https://wonder.cdc.gov/nndss/documents/2016_NNDSS_Publication_Criteria.pdf, /nndss/documents/2016_NNDSS_Publication_Criteria.pdf. See also https://ndc.services.cdc.gov/wp-content/uploads/Users_guide_WONDER_tables_cleared_final.pdf, Guide to Interpreting Provisional and Finalized NNDSS Data. Population estimates for incidence rates are July 1st, 2016 estimates obtained from the National Center for Health Statistics (NCHS) postcensal estimates of the resident population of the United States for July 1, 2011 - July 1, 2016, by year, county, single year of age (range: 0 to 85 years), bridged-race (white, black or African American, American Indian or Alaska Native, Asian, or Pacific Islander), Hispanic ethnicity (not Hispanic or Latino, Hispanic or Latino), and sex (Vintage 2016), prepared under a collaborative arrangement with the U.S. Census Bureau. Population estimates for states as of June 26, 2017 are available at https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm, https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm. Population estimates for territories are the 2016 mid-year estimates from the U.S. Census Bureau International Data Base accessed on July 24, 2017 at https://www.census.gov/population/international/data/idb/informationGateway.php, https://www.census.gov/population/international/data/idb/informationGateway.php. The choice of population denominators for incidence is based on the availability of population data at the time of publication preparation. Annual tables for 2016 and later years are available on https://wonder.cdc.gov/nndss/nndss_annual_tables_menu.asp, CDC WONDER. Annual summary reports from 1993-2015 are available as published in the https://www.cdc.gov/mmwr/mmwr_nd/index.html, MMWR. NNDSS annual tables since 1952 are available at https://stacks.cdc.gov/nndss, CDC Stacks (once in CDC Stacks select "Annual Reports" in the "Genre" box to the left). Suggested Citation: Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System, 2016 Annual Tables of Infectious Disease Data. Atlanta, GA. CDC Division of Health Informatics and Surveillance, 2017. Available at: https://www.cdc.gov/nndss/data-statistics/infectious-tables/index.html, https://www.cdc.gov/nndss/data-statistics/infectious-tables/index.html. https://www.cdc.gov/nndss/, National Notifiable Diseases Surveillance System Provided by https://wonder.cdc.gov, CDC WONDER